Ignite Creation Date:
2024-05-06 @ 8:06 PM
Last Modification Date:
2024-10-26 @ 3:20 PM
Study NCT ID:
NCT06250075
Status:
COMPLETED
Last Update Posted:
2024-05-13
First Post:
2024-01-05
Brief Title:
Effects of the Use of Probiotics on the Intestinal Microbiota of Patients With Gastric Cancer
Sponsor:
Universidade Federal do Amazonas
Organization:
Universidade Federal do Amazonas
Study Overview
Official Title:
Effects of the Use of Probiotics on the Intestinal Microbiota Clinical-Nutritional and Immunological Status of Patients Gastrectomized for Gastric Cancer A Randomized Clinical Trial
Status:
COMPLETED
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PRONIC-G
Brief Summary:
The objective of this randomized controlled prospective clinical study composed of 5 groups G1 G2 G3 G4 and G5 is Evaluate the intestinal microbiota profile nutritional immunological status and inflammatory profile before and after total or partial removal surgery gastrectomies for gastric cancer in a patient using probiotic supplements The main questions it aims to answer are
probiotics are capable of modulating the immune response and microbiota in cancer patients who will undergo surgery
surgery itself alters the immunological pattern and microbiota of cancer patients Participants will be divided into groups for evaluation and the G1 intervention group will take probiotic capsules
The researchers will compare groups G1 G2 with G3 negative control group to see if there are differences between using probiotics or not in controlling the immune response and if there are significant changes in their intestinal microbiota Groups G4 and G5 will also be compared where in these we will only measure the power of the use of probiotics in reducing surgical complications in the postoperative period
probiotics are capable of modulating the immune response and microbiota in cancer patients who will undergo surgery
surgery itself alters the immunological pattern and microbiota of cancer patients Participants will be divided into groups for evaluation and the G1 intervention group will take probiotic capsules
The researchers will compare groups G1 G2 with G3 negative control group to see if there are differences between using probiotics or not in controlling the immune response and if there are significant changes in their intestinal microbiota Groups G4 and G5 will also be compared where in these we will only measure the power of the use of probiotics in reducing surgical complications in the postoperative period
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None